210 related articles for article (PubMed ID: 33244084)
21. A small molecule screen in stem-cell-derived motor neurons identifies a kinase inhibitor as a candidate therapeutic for ALS.
Yang YM; Gupta SK; Kim KJ; Powers BE; Cerqueira A; Wainger BJ; Ngo HD; Rosowski KA; Schein PA; Ackeifi CA; Arvanites AC; Davidow LS; Woolf CJ; Rubin LL
Cell Stem Cell; 2013 Jun; 12(6):713-26. PubMed ID: 23602540
[TBL] [Abstract][Full Text] [Related]
22. Oligodendrocytes contribute to motor neuron death in ALS via SOD1-dependent mechanism.
Ferraiuolo L; Meyer K; Sherwood TW; Vick J; Likhite S; Frakes A; Miranda CJ; Braun L; Heath PR; Pineda R; Beattie CE; Shaw PJ; Askwith CC; McTigue D; Kaspar BK
Proc Natl Acad Sci U S A; 2016 Oct; 113(42):E6496-E6505. PubMed ID: 27688759
[TBL] [Abstract][Full Text] [Related]
23. Neuroprotective Effect of Human Adipose Stem Cell-Derived Extract in Amyotrophic Lateral Sclerosis.
Jeon GS; Im W; Shim YM; Lee M; Kim MJ; Hong YH; Seong SY; Kim M; Sung JJ
Neurochem Res; 2016 Apr; 41(4):913-23. PubMed ID: 26646002
[TBL] [Abstract][Full Text] [Related]
24. In-vivo genetic ablation of metabotropic glutamate receptor type 5 slows down disease progression in the SOD1
Bonifacino T; Provenzano F; Gallia E; Ravera S; Torazza C; Bossi S; Ferrando S; Puliti A; Van Den Bosch L; Bonanno G; Milanese M
Neurobiol Dis; 2019 Sep; 129():79-92. PubMed ID: 31102766
[TBL] [Abstract][Full Text] [Related]
25. Systemic treatment with adipose-derived mesenchymal stem cells ameliorates clinical and pathological features in the amyotrophic lateral sclerosis murine model.
Marconi S; Bonaconsa M; Scambi I; Squintani GM; Rui W; Turano E; Ungaro D; D'Agostino S; Barbieri F; Angiari S; Farinazzo A; Constantin G; Del Carro U; Bonetti B; Mariotti R
Neuroscience; 2013 Sep; 248():333-43. PubMed ID: 23727509
[TBL] [Abstract][Full Text] [Related]
26. Targeting the Sigma-1 Receptor via Pridopidine Ameliorates Central Features of ALS Pathology in a SOD1
Ionescu A; Gradus T; Altman T; Maimon R; Saraf Avraham N; Geva M; Hayden M; Perlson E
Cell Death Dis; 2019 Mar; 10(3):210. PubMed ID: 30824685
[TBL] [Abstract][Full Text] [Related]
27. Neural stem cells LewisX+ CXCR4+ modify disease progression in an amyotrophic lateral sclerosis model.
Corti S; Locatelli F; Papadimitriou D; Del Bo R; Nizzardo M; Nardini M; Donadoni C; Salani S; Fortunato F; Strazzer S; Bresolin N; Comi GP
Brain; 2007 May; 130(Pt 5):1289-305. PubMed ID: 17439986
[TBL] [Abstract][Full Text] [Related]
28. Prolonged survival and milder impairment of motor function in the SOD1 ALS mouse model devoid of fibroblast growth factor 2.
Thau N; Jungnickel J; Knippenberg S; Ratzka A; Dengler R; Petri S; Grothe C
Neurobiol Dis; 2012 Aug; 47(2):248-57. PubMed ID: 22542539
[TBL] [Abstract][Full Text] [Related]
29. Granulocyte-colony stimulating factor improves outcome in a mouse model of amyotrophic lateral sclerosis.
Pitzer C; Krüger C; Plaas C; Kirsch F; Dittgen T; Müller R; Laage R; Kastner S; Suess S; Spoelgen R; Henriques A; Ehrenreich H; Schäbitz WR; Bach A; Schneider A
Brain; 2008 Dec; 131(Pt 12):3335-47. PubMed ID: 18835867
[TBL] [Abstract][Full Text] [Related]
30. Lead exposure stimulates VEGF expression in the spinal cord and extends survival in a mouse model of ALS.
Barbeito AG; Martinez-Palma L; Vargas MR; Pehar M; Mañay N; Beckman JS; Barbeito L; Cassina P
Neurobiol Dis; 2010 Mar; 37(3):574-80. PubMed ID: 19914377
[TBL] [Abstract][Full Text] [Related]
31. Could Sirtuin Activities Modify ALS Onset and Progression?
Tang BL
Cell Mol Neurobiol; 2017 Oct; 37(7):1147-1160. PubMed ID: 27942908
[TBL] [Abstract][Full Text] [Related]
32. Pericytes Extend Survival of ALS SOD1 Mice and Induce the Expression of Antioxidant Enzymes in the Murine Model and in IPSCs Derived Neuronal Cells from an ALS Patient.
Coatti GC; Frangini M; Valadares MC; Gomes JP; Lima NO; Cavaçana N; Assoni AF; Pelatti MV; Birbrair A; de Lima ACP; Singer JM; Rocha FMM; Da Silva GL; Mantovani MS; Macedo-Souza LI; Ferrari MFR; Zatz M
Stem Cell Rev Rep; 2017 Oct; 13(5):686-698. PubMed ID: 28710685
[TBL] [Abstract][Full Text] [Related]
33. VEGF delivery with retrogradely transported lentivector prolongs survival in a mouse ALS model.
Azzouz M; Ralph GS; Storkebaum E; Walmsley LE; Mitrophanous KA; Kingsman SM; Carmeliet P; Mazarakis ND
Nature; 2004 May; 429(6990):413-7. PubMed ID: 15164063
[TBL] [Abstract][Full Text] [Related]
34. GDNF is trophic for mouse motoneurons that express a mutant superoxide dismutase (SOD-1) gene.
Derby ML; Giuliano R; Figlewicz DA; Bohn MC
Amyotroph Lateral Scler Other Motor Neuron Disord; 2000 Mar; 1(2):113-22. PubMed ID: 11467048
[TBL] [Abstract][Full Text] [Related]
35. Human glial-restricted progenitor transplantation into cervical spinal cord of the SOD1 mouse model of ALS.
Lepore AC; O'Donnell J; Kim AS; Williams T; Tuteja A; Rao MS; Kelley LL; Campanelli JT; Maragakis NJ
PLoS One; 2011; 6(10):e25968. PubMed ID: 21998733
[TBL] [Abstract][Full Text] [Related]
36. Enhancing NAD+ Salvage Pathway Reverts the Toxicity of Primary Astrocytes Expressing Amyotrophic Lateral Sclerosis-linked Mutant Superoxide Dismutase 1 (SOD1).
Harlan BA; Pehar M; Sharma DR; Beeson G; Beeson CC; Vargas MR
J Biol Chem; 2016 May; 291(20):10836-46. PubMed ID: 27002158
[TBL] [Abstract][Full Text] [Related]
37. Bisperoxovanadium promotes motor neuron survival and neuromuscular innervation in amyotrophic lateral sclerosis.
Wang J; Tierney L; Mann R; Lonsway T; Walker CL
Mol Brain; 2021 Oct; 14(1):155. PubMed ID: 34635126
[TBL] [Abstract][Full Text] [Related]
38. Slowing disease progression in the SOD1 mouse model of ALS by blocking neuregulin-induced microglial activation.
Liu J; Allender E; Wang J; Simpson EH; Loeb JA; Song F
Neurobiol Dis; 2018 Mar; 111():118-126. PubMed ID: 29278738
[TBL] [Abstract][Full Text] [Related]
39. 7,8-Dihydroxyflavone improves motor performance and enhances lower motor neuronal survival in a mouse model of amyotrophic lateral sclerosis.
Korkmaz OT; Aytan N; Carreras I; Choi JK; Kowall NW; Jenkins BG; Dedeoglu A
Neurosci Lett; 2014 Apr; 566():286-91. PubMed ID: 24637017
[TBL] [Abstract][Full Text] [Related]
40. Molecular chaperone mediated late-stage neuroprotection in the SOD1(G93A) mouse model of amyotrophic lateral sclerosis.
Novoselov SS; Mustill WJ; Gray AL; Dick JR; Kanuga N; Kalmar B; Greensmith L; Cheetham ME
PLoS One; 2013; 8(8):e73944. PubMed ID: 24023695
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
